BACKGROUND Medication safety is increasingly of scope to face the challenge of patient safety in growing ageing populations. Developing positive patient safety cultures is acknowledged a primary goal to improve patient safety, but evidence on interventions to do so is inconclusive, not reflecting voices of nursing home residents- and their loved ones. Nursing home residents are often cognitively and physically impaired, therefore highly reluctant on frontline health care providers. Thus, studies on interventions to improve medication safety through patient safety culture among health care providers are needed to guide clinical practice within nursing homes, using integrating methods to ensure power of perspectives. OBJECTIVE The primary aim of the SAME study is to improve medication safety for elderly residing nursing homes focusing on patient safety culture in co-creation with residents, their relatives and frontline health care staff. METHODS A fully integrated mixed methods study covering a co-creative process with an integrated knowledge translational (IKT) approach. Patient safety culture within nursing homes will be explored through qualitative focus groups (Stage 1) to inform the development of an intervention in a multidisciplinary panel (Stage 2). Evaluation of the intervention will be done in a randomised controlled trial (RCT) set at nursing homes (Stage 3). The primary outcome will be changes in mean scale score of an adapted version of the Danish “Safety Attitudes Questionnaire” (SAQ-DK) for use in nursing homes. Patient safety related outcomes as risk-situation drugs, contacts to health care, diagnoses and mortality will be analysed through quantitative data collected through national registers. Finally, mixed methods analysis on patient safety culture in nursing homes will be done (stage 4), integrating qualitative data (Stage 1) and quantitative data (Stage 3) to comprehensively understand patient safety culture as a key to medication safety. RESULTS The SAME study is ongoing. Idea-and experience-groups (Stage 1) were carried out from April to September 2021 and the workshop in September 2021. Baseline SAQ-DK prim-data was collected in January 2022 with expected follow-up in January 2023. We expect to finish data-analysis in spring 2024. CONCLUSIONS The SAME study will help generate evidence on patient safety culture that could help to inform- and guide future improvement-efforts within primary care settings, within political- and scientifical scope to meet an increasing challenge of medication safety. CLINICALTRIAL This study is registered at The North Denmark Region (2021-015), at Aalborg University (2021-068-01412) and in ClinicalTrials.gov (Identifier: NCT04990986).
Background Medication safety is increasingly challenging patient safety in growing aging populations. Developing positive patient safety cultures is acknowledged as a primary goal to improve patient safety, but evidence on the interventions to do so is inconclusive. Nursing home residents are often cognitively and physically impaired and are therefore highly reliant on frontline health care providers. Thus, interventions to improve medication safety of nursing home residents through patient safety culture among providers are needed. Using cocreative partnerships, integrating knowledge of residents and their relatives, and ensuring managerial support could be beneficial. Objective The primary aim of the Safe Medication of Nursing Home Residents Through Development and Evaluation of an Intervention (SAME) study is to improve medication safety for nursing home residents through developing an intervention by gaining experiential knowledge of patient safety culture in cocreative partnerships, integrating knowledge of residents and their relatives, and ensuring managerial support. Methods The fully integrated mixed method study will be conducted using an integrated knowledge translation approach. Patient safety culture within nursing homes will first be explored through qualitative focus groups (stage 1) including nursing home residents, their relatives, and frontline health care providers. This will inform the development of an intervention in a multidisciplinary panel (stage 2) including cocreators representing the medication management process across the health care system. Evaluation of the intervention will be done in a randomized controlled trial set at nursing homes (stage 3). The primary outcome will be changes in the mean scale score of an adapted version of the Danish “Safety Attitudes Questionnaire” (SAQ-DK) for use in nursing homes. Patient safety–related outcomes will be collected through Danish health registers to assess safety issues and effects, including medication, contacts to health care, diagnoses, and mortality. Finally, a mixed methods analysis on patient safety culture in nursing homes will be done (stage 4), integrating qualitative data (stage 1) and quantitative data (stage 3) to comprehensively understand patient safety culture as a key to medication safety. Results The SAME study is ongoing. Focus groups were carried out from April 2021 to September 2021 and the workshop in September 2021. Baseline SAQ-DK data were collected in January 2022 with expected follow-up in January 2023. Final data analysis is expected in spring 2024. Conclusions The SAME study will help not only to generate evidence on interventions to improve medication safety of nursing home residents through patient safety culture but also to give insight into possible impacts of using cocreativity to guide the development. Thus, findings will address multiple gaps in evidence to guide future patient safety improvement efforts within primary care settings of political and scientific scope. Trial Registration ClinicalTrials.gov NCT04990986; https://clinicaltrials.gov/ct2/show/NCT04990986 International Registered Report Identifier (IRRID) DERR1-10.2196/43538
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.